PD-L1 28-8 pharmDx by IHC w/Interp, nivolumab (OPDIVO)
Order Name
PD-L1 28-8 IHC
Test Number: 6906285
Revision Date 12/12/2022
Test Number: 6906285
Revision Date 12/12/2022
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
PD-L1 28-8 pharmDx by IHC w/Interp, nivolumab (OPDIVO)
|
Immunohistochemistry |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | Tumor Tissue | Paraffin Block | Room Temperature | |
| Instructions | Notes: Three unstained tissue slides Specimen Type: Tissue block or slide Specimen Storage: Room temperature. Specimen Collection: Tissue should be fixed in 10% neutral buffered formalin for no more than 72 hours. Embed in paraffin. Special Instructions: NOTE: This test number is used for tracking oncology IHC specimens to the laboratory. Bill codes will be added when testing is complete, based on the processes performed in the laboratory. |
|||
| GENERAL INFORMATION | |
|---|---|
| Expected TAT | 5-9 days |
| Performing Labcorp Test Code | 480588 |
| Notes | Labcorp Test Code: 480588 |
| Lab Section | Reference Lab |